Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO.
The post Major Bayer shareholder Harris backs CEO’s focus on internal restructuring appeared first on Reuters News Agency.